Skip to main content
Clinical Trials/ACTRN12614000166673
ACTRN12614000166673
Recruiting
未知

A randomised controlled feasibility trial to determine the efficacy of diabetes specific formulae to reduce exogenous insulin doses required to obtain acceptable glycaemic control when compared to the standard nutritional formula in critically ill tube fed patients

Mater Foundation and Mater Research Institute0 sites54 target enrollmentFebruary 11, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Mater Foundation and Mater Research Institute
Enrollment
54
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 11, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mater Foundation and Mater Research Institute

Eligibility Criteria

Inclusion Criteria

  • A patient is receiving exclusive enteral nutrition and requires an insulin infusion. Patients with two consecutive blood glucose levels \> 10mmol/L are likely to commence on an insulin infusion based on the units’ glucose management protocol.

Exclusion Criteria

  • The exclusion criteria for this study include patients \<18, declined consent by patient/ legally authorised representative, or if recruitment to the study is deemed clinically inappropriate by the treating physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials